A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

NCT00001122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nelfinavir mesylate
DRUG: Efavirenz
DRUG: Stavudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)